Meridian Bioscience
In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More
News items for the week of Jan. 30, 2023.
360Dx Top 30 Ends 2022 With 2 Percent Dip in December
Of the 30 companies in the index, nine saw their stock prices rise, while 21 firms' share prices decreased.
Meridian Bioscience Fiscal Q4 Revenues Fall 14 Percent, Full-Year Revenues Grow 5 Percent
The firm's diagnostics segment revenues climbed 14 percent year over year in fiscal Q4, while life sciences revenues were down 37 percent.
Meridian Bioscience Fiscal Q3 Revenues Rise 7 Percent as Acquisition Looms
The company's diagnostics revenues rose 36 percent, while life sciences revenues fell 21 percent.
FDA Reissues EUA for Meridian Bioscience COVID-19 Test After Omicron Variant Trouble
The test, which received Emergency Use Authorization from US regulators in late 2021, had to be updated in order to detect the variant.
Apr 6, 2022
Feb 1, 2022
360Dx Top 30 Plummets 17 Percent in January
Nov 12, 2021
Nov 12, 2021